SEARCH

SEARCH BY CITATION

References

  • Adell A., Celada P. and Artigas F. (2001) The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J. Neurochem. 79, 172182.
  • Ase A. R., Reader T. A., Hen R., Riad M. and Descarries L. (2001) Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knock-out mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem. 78, 619630.
  • Auerbach S. B. and Hjorth S. (1995) Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 352, 597606.
  • Bel N. and Artigas F. (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229, 101103.
  • Bel N. and Artigas F. (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15, 243245.
  • Blier P. and De Montigny C. (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J. Neurosci. 3, 12701278.
  • Boschert U., Amara D. A., Segu L. and Hen R. (1994) The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58, 167182.
  • Bosker F. J., Van Esseveldt K. E., Klompmakers A. A. and Westenberg H. G. (1995a) Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology (Berl). 117, 358363.
  • Bosker F. J., Klompmakers A. A. and Westenberg H. G. (1995b) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology. 34, 501508.
  • Bouwknecht J. A., Hijzen T. H., Van Der Gugten J., Maes R. A., Hen R. and Olivier B. (2002) 5-HT(1B) receptor knockout mice show no adaptive changes in 5-HT(1A) receptor function as measured telemetrically on body temperature and heart rate responses. Brain Res. Bull. 57, 93102.
  • Caccia S., Anelli M., Codegoni A. M., Fracasso C. and Garattini S. (1993) The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. Br. J. Pharmacol. 110, 355359.
  • Cremers T. I., Spoelstra E. N., De Boer P., Bosker F. J., Mork A., Den Boer J. A., Westerink B. H. and Wikstrom H. V. (2000) Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram. Eur. J. Pharmacol. 397, 351357.
  • Cremers T. I., Wiersma L. J., Bosker F. J., Den Boer J. A., Westerink B. H. and Wikstrom H. V. (2001) Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? Biol. Psychiatry 50, 1321.
  • Daws L. C., Gould G. G., Teicher S. D., Gerhardt G. A. and Frazer A. (2000) 5-HT1B receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J. Neurochem. 75, 21132122.
  • Dremencov E., Gur E., Lerer B. and Newman M. E. (2000) Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis. Eur. Neuropsychopharmacol. 10, 229236.
  • Engel G., Göthert M., Hoyer D., Schlicker E. and Hillenbrand K. (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 332, 17.
  • Evrard A., Laporte A. M., Chastanet M., Hen R., Hamon M. and Adrien J. (1999) 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice. Eur. J. Neurosci. 11, 38233831.
  • Franklin K. B. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, Toronto/San Diego.
  • Fuller R. W. (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55, 163167.
  • Gardier A. M., Malagié I., Trillat A.-C., Jacquot C. and Artigas F. (1996) A review: role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10, 1627.
  • Gardier A. M., Gruwez B., Trillat A.-C., Jacquot C., Hen R. and Bourin M. (2001) Interaction between 5-HT(1A) and 5-HT(1B) receptors: effects of 8-OH-DPAT-induced hypothermia in 5-HT(1B) receptor knockout mice. Eur. J. Pharmacol. 421, 171175.
  • Gartside S. E., Umbers V., Hajos M. and Sharp T. (1995) Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115, 10641070.
  • Gobbi M., Crespi D., Foddi M. C., Fracasso C., Mancini L., Parotti L. and Mennini T. (1997) Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch. Pharmacol. 356, 2228.
  • Göthert M., Schlicker E., Fink K. and Classen K. (1987) Effects of RU 24969 on serotonin release in rat brain cortex: further support for the identity of serotonin autoreceptors with 5-HT1B sites. Arch. Int. De Pharmacodyn. 288, 3142.
  • Gundlah C., Hjorth S. and Auerbach S. B. (1997) Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36, 475482.
  • Hervas I., Bel N., Fernandez A. G., Palacios J. M. and Artigas F. (1998) In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn Schmiedebergs Arch. Pharmacol. 358, 315322.
  • Hervas I., Queiroz C. M., Adell A. and Artigas F. (2000) Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br. J. Pharmacol. 130, 160166.
  • Hjorth S. and Auerbach S. B. (1999) Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor. Brain Res. 835, 224228.
  • Hjorth S. and Sharp T. (1993) In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (–)penbutolol. J. Pharmacol. Exp. Ther. 265, 707712.
  • Hjorth S., Bengtsson H. J., Kullberg A., Carlzon D., Peilot H. and Auerbach S. B. (2000) Serotonin autoreceptor function and antidepressant drug action. J. Psychopharmacol. 14, 177185.
  • Invernizzi R., Bramante M. and Samanin R. (1995) Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 696, 6266.
  • Jacobs B. L. and Azmitia E. C. (1992) Structure and function of the brain serotonin system. Physiol. Rev. 72, 165229.
  • Justice J. B. (1993) Quantitative microdialysis of neurotransmitters. J. Neurosci. Meth. 48, 261276.
  • Knobelman D. A., Hen R., Blendy J. A. and Lucki I. (2001) Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. J. Pharmacol. Exp. Ther. 298, 10921100.
  • Le Poul E., Laaris N., Hamon M. and Lanfumey L. (1997) Fluoxetine-induced desensitization of somatodendritic 5-HT1A autoreceptors is independent of glucocorticoid(s). Synapse 27, 303312.
  • Le Poul E., Boni C., Hanoun N., Laporte A.-M., Laaris N., Chauveau J., Hamon M. and Lanfumey L. (2000) Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39, 110122.
  • Malagié I., Trillat A.-C., Douvier E., Anmella M.-C., Dessalles M.-C., Jacquot C. and Gardier A. M. (1996) Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 354, 785790.
  • Malagié I., Deslandes A. and Gardier A. M. (2000) Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis Eur. J. Pharmacol. 403, 5565.
  • Malagié I., Trillat A.-C., Bourin M., Jacquot C., Hen R. and Gardier A. M. (2001) 5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J. Neurochem. 76, 865871.
  • Malagié I., David D. J., Jolliet P., Hen R., Bourin M. and Gardier A. M. (2002) Improved efficacy of fluoxetine in increasing hippocampal 5-HT outflow in 5-HT1B receptor knockout mice. Eur. J. Pharmacol. 443, 99104.
  • Meltzer H. Y. and Lowy M. T. (1987) The serotonin hypothesis of depression, in Psychopharmacology: The Third Generation of Progress (MeltzerH. Y., ed.), pp. 513526. Raven Press, New York.
  • Moret C. and Briley M. (1996) Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur. J. Pharmacol. 295, 189197.
  • Nemeroff C. B. (1993) Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression. J. Clin. Psychopharmacol. 13, 10S17S.
  • Parsons L. and Justice J. B. (1994) Quantitavive approaches to in vivo brain microdialysis. Crit. Rev. Neurobiol. 8, 189220.
  • Pineyro G. and Blier P. (1996) Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration. J. Pharmacol. Exp. Ther. 276, 697707.
  • Pineyro G., Blier P., Dennis T. and De Montigny C. (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J. Neurosci. 14, 30363047.
  • Saudou F., Aït Amara D., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.-C. and Hen R. (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265, 18751878.
  • Sayer T. J., Hannon S. D., Redfern P. H. and Martin K. F. (1999) Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment. Br. J. Pharmacol. 126, 17771784.
  • Shippenberg T. S., Hen R. and He M. (2000) Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the serotonin (1B) receptor. J. Neurochem. 75, 258265.
  • Thomas D. R., Nelson D. R. and Johnson A. M. (1987) Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology (Berl.) 93, 193200.
  • Trillat A.-C., Malagié I., Scearce K., Anmella M.-C., Jacquot C., Hen R. and Gardier A. M. (1997) Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies. J. Neurochem. 69, 20192025.